You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for New Drug Application (NDA): 020256


✉ Email this page to a colleague

« Back to Dashboard


NDA 020256 describes NEUROLITE, which is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. Additional details are available on the NEUROLITE profile page.

The generic ingredient in NEUROLITE is technetium tc-99m bicisate kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m bicisate kit profile page.
Summary for 020256
Tradename:NEUROLITE
Applicant:Lantheus Medcl
Ingredient:technetium tc-99m bicisate kit
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020256
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEUROLITE technetium tc-99m bicisate kit INJECTABLE;INJECTION 020256 NDA Lantheus Medical Imaging, Inc. 11994-006 11994-006-02 2 KIT in 1 PACKAGE, COMBINATION (11994-006-02) / 1 KIT in 1 KIT * 1 INJECTION in 1 VIAL (11994-002-01) * 1 mL in 1 VIAL (11994-004-01)
NEUROLITE technetium tc-99m bicisate kit INJECTABLE;INJECTION 020256 NDA Lantheus Medical Imaging, Inc. 11994-006 11994-006-05 5 KIT in 1 PACKAGE, COMBINATION (11994-006-05) / 1 KIT in 1 KIT * 1 INJECTION in 1 VIAL (11994-002-01) * 1 mL in 1 VIAL (11994-004-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Nov 23, 1994TE:RLD:Yes

Expired US Patents for NDA 020256

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medcl NEUROLITE technetium tc-99m bicisate kit INJECTABLE;INJECTION 020256-001 Nov 23, 1994 ⤷  Try a Trial ⤷  Try a Trial
Lantheus Medcl NEUROLITE technetium tc-99m bicisate kit INJECTABLE;INJECTION 020256-001 Nov 23, 1994 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.